Dr Gemma Taylor is a Reader at the University of Bath, and a Cancer Research UK Population Researcher Fellow. Gemma is an epidemiologist and behavioural scientist, and her research covers three main areas: 1) disentangling the causal nature of the association between smoking tobacco and mental health, 2) identifying intervention targets using experimental and epidemiological methods, and 3) co-design and testing smoking cessation interventions for use in NHS psychological services. Gemma's expertise are evidenced by prestigious awards from BMJ, Welcome Trust, International Society for Behavioural Medicine, Society for the Study of Addiction, and the UK Society for Behavioural Medicine. Gemma has also published her academic research in peer-reviewed journals including BMJ, Lancet Psychiatry, International Journal of Epidemiology and the Cochrane Database of Systematic Reviews.
- Describe the epidemiology of smoking in people with mental illness
- Explain the three associations between smoking and mental ill-health
- Identify and describe two benefits of psychological models to treat co-morbid smoking and mental ill-health
The CME/CEU registration period has closed for this live activity. Credit will be available for the recorded version of the webinar by November.
Certificates of Attendance
Click here to generate a certificate of attendance for participating on this webinar.
The University of California, San Francisco (UCSF) School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
UCSF designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the webinar activity.
Advance Practice Registered Nurses and Registered Nurses: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 CreditTM issued by organizations accredited by the ACCME.
Physician Assistants: The National Commission on Certification of Physician Assistants (NCCPA) states that the AMA PRA Category 1 CreditTM are acceptable for continuing medical education requirements for recertification.
California Pharmacists: The California Board of Pharmacy accepts as continuing professional education those courses that meet the standard of relevance to pharmacy practice and have been approved for AMA PRA category 1 CreditTM. If you are a pharmacist in another state, you should check with your state board for approval of this credit.
California Psychologists: The California Board of Psychology recognizes and accepts for continuing education credit courses that are provided by entities approved by the Accreditation Council for Continuing Medical Education (ACCME). AMA PRA Category 1 CreditTM is acceptable to meeting the CE requirements for the California Board of Psychology. Providers in other states should check with their state boards for acceptance of CME credit.
California Behavioral Science Professionals: University of California, San Francisco School of Medicine (UCSF) is approved by the California Association of Marriage and Family Therapists to sponsor continuing education for behavioral health providers. UCSF maintains responsibility for this program/course and its content.
Course meets the qualifications for 1.0 hour of continuing education credit for LMFTs, LCSWs, LPCCs, and/or LEPs as required by the California Board of Behavioral Sciences. Provider # 64239.
Accreditation for Addiction Counselors
The UCSF office of continuing medical education is accredited by the California Consortium of Addiction Programs and Professionals (CCAPP), to provide continuing education credit for California addiction counselors. UCSF designates this live, virtual activity, for a maximum of 1.0 CCAPP credit. Addiction counselors should claim only the credit commensurate with the extent of their participation in the activity. Provider number: 7-20-322-0722.
This UCSF CME activity was planned and developed to uphold academic standards to ensure balance, independence, objectivity, and scientific rigor; adhere to requirements to protect health information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA); and include a mechanism to inform learners when unapproved or unlabeled uses of therapeutic products or agents are discussed or referenced.
All speakers, planning committee members and reviewers have disclosed they have no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Anita Browning, Christine Cheng, Brian Clark, Pamela Ling, MD, MPH, Jennifer Matekuare, Ma Krisanta Pamatmat, MPH, Catherine Bonniot Saucedo, Gemma Taylor, PhD, and Aria Yow, MA.
- "Smoking and mental health - the tobacco withdrawal cycle"- Video played during Dr. Taylor's webinar presentation